TABLE 1

Study characteristics

StudyYrNo. enrolledNo. quantifiable on index and reference testLocationPatient populationAge% Female% on ARTTest and manufacturera
Avidor et al. (21)2017383254IsraelHIV+, routine careRoche TaqMan
Bruzzone et al. (19)20175041ItalyHIV+ laboratory samplesVersant
Ceffa et al. (11)2015300274MalawiPediatric and adult HIV+, routine care100Abbott
Garrett et al. (14)20164242South AfricaHIV+ women in CAPRISA 002 study3310066Roche TaqMan
Gous et al., laboratory samples (12)20164220South AfricaQuality assessment HIV+ laboratory samplesRoche TaqMan
Gous et al., patient samples (12)201615853South AfricaHIV+, routine care4254100Roche TaqMan
Gueudin et al. (15)2016295162FranceHIV+, routine care20Abbott
Jordan et al. (16)2016764390Europe, USAAdult HIV+, routine care4528Abbott
Kulkarni et al. (22)2017219167IndiaHIV+, routine care3852Abbott
Mor et al. (17)2015404146IsraelHIV+, routine careNucliSens v2.0
Moyo et al. (18)2016302277BotswanaHIV+, ART naive, rural patients0Abbott
Nash et al. (20)201724689IndiaAdult HIV+, routine care414070Roche TaqMan
Swathirajan et al. (23)201710396IndiaHIV+, routine careAbbott
  • a Full names and manufacturers of reference tests are the following: Abbot, Abbott RealTime HIV-1 m2000rt, Abbott Molecular; Roche TaqMan, COBAS AmpliPrep/COBAS TaqMan, Roche Diagnostics; NucliSENS, NucliSENS EasyQ HIV-1 v2.0, bioMérieux; Versant, HIV-1 RNA 1.5 assay, Siemens HealthCare Diagnostics.